BAT's BTV Launches Second Fund Focused on Health and Innovation

BAT by 2FIRSTS.ai
Dec.19.2024
BAT's BTV Launches Second Fund Focused on Health and Innovation
BAT's Btomorrow Ventures launches second fund with focus on health and innovation, demonstrating commitment to smoke-free world.

On December 18, British American Tobacco (BAT) announced on its official website that its venture capital arm, Btomorrow Ventures (BTV), has launched its second fund. The fund will mainly focus on health and wellness businesses, in line with BAT's strategic exploration of non-nicotine products. The launch of the new fund comes with an additional commitment of £200 million in investments, showcasing BAT's dedication to creating a "smoke-free world.

 

The Business Development Director of BAT, James Barrett, stated,

 

The launch of the second fund is an important demonstration of BAT's confidence in BTV as a key part of BAT's transformation agenda, which aims to turn BAT into a diversified consumer goods business. By focusing on health and innovation investments, we are committed to advancing BAT's smoke-free world agenda, building on the success of BTV's first fund.

 

Since its first investment in 2020, BTV's first fund has made 28 investments, primarily focusing on early-stage financing to support companies developing innovative products that align with the vision of creating a smoke-free world with BAT, and to reduce risk in new product categories.

 

Most of the initial £150 million fund has already been deployed or committed, including investments in the American functional beverage brand Moment and the Canadian caffeinated chocolate brand AWAKE.

 

The second fund is a supplement to the BTV Impact program launched earlier this year, which aims to harness the power of the venture capital community to support and advance its sustainability, diversity, and inclusivity agendas.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT's H1 2025 Financial Report: Vuse Sales Down Nearly 13%, Velo Revenue up Over 40%
BAT reported H1 2025 revenue of £12.07 billion, down 2.2% due to FX, but up 1.8% at constant rates. Smoke-free products made up 18.2% of total revenue, with Velo sales rising 40.6%. BAT maintained its full-year outlook and raised its 2025 share buyback to £1.1 billion.
Jul.31 by 2FIRSTS.ai
UK disposablevapee ban survey: 85% of users switch to compliant devices, 26% turn to the illegal market
UK disposablevapee ban survey: 85% of users switch to compliant devices, 26% turn to the illegal market
New study reveals 85% of e-cigarette users switch to reusable devices, highlighting challenges in transition and increased tobacco use.
Aug.08 by 2FIRSTS.ai
U.S. Report: From Jujutsu Kaisen to Oscar-Winning Films, Tobacco Content Is Permeating Popular Media
U.S. Report: From Jujutsu Kaisen to Oscar-Winning Films, Tobacco Content Is Permeating Popular Media
While teen vaping hit a 10-year low, tobacco imagery in film and TV rose 70% in 2023, exposing around 17 million youths. Studies show such exposure triples the risk of nicotine use among teens, potentially undermining tobacco control efforts. 80% of Oscar-nominated films featured tobacco content, and music videos with tobacco imagery have surpassed 5 billion views.
Jul.03 by 2FIRSTS.ai
Product | GAAGEE Unveils Nova Link/Core Open-System Vape with 3-Inch Touchscreen and AI Assistant
Product | GAAGEE Unveils Nova Link/Core Open-System Vape with 3-Inch Touchscreen and AI Assistant
GAAGEE launched the Nova Link and Nova Core open-system vapes with a smartphone-style design, 2.5D touchscreens, and app support. Nova Link has a 1700mAh battery, 2ml pod, and firmware updates via Pava App. Listed on the website but not yet for sale, the devices debuted at the Dubai Vape Expo.
Jul.22 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Yinghe Technology's Sikary reports revenue of 1.274 billion yuan in 2025 first half, with net profit of 3.20 billion yuan
Yinghe Technology's Sikary reports revenue of 1.274 billion yuan in 2025 first half, with net profit of 3.20 billion yuan
Yinghe Technology's subsidiary Sikary reports 12.74 billion yuan in revenue and 3.20 billion yuan in net profit.
Aug.25 by 2FIRSTS.ai